[ ¹⁸ F]-Labeled Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography in Staging and Restaging Patients With Breast Cancer

David Groheux

Department of Nuclear Medicine, Saint-Louis Hospital, Paris, France

Sofia C. Vaz

Department of Nuclear Medicine and Radiopharmacology, Champalimaud Clinical Center, Champalimaud Foundation, Lisbon, Portugal

Lioe-Fee de Geus-Oei

Department of Radiology, Leiden University Medical Center, Leiden, the Netherlands

Elizabeth H. Dibble

Warren Alpert School of Medicine Brown University Providence Rhode Island USA

Gary A. Ulaner

Department of Molecular Imaging and Therapy, Hoag Family Cancer Institute, Newport Beach, CA

Gary J.R. Cook

Department of Cancer Imaging, King's College London, London, United Kingdom

Elif Hindié

Department of Nuclear Medicine, Bordeaux University Hospital, University of Bordeaux, Bordeaux, France

Philip Poortmans

Department of Radiation Oncology Iridium Netwerk Wilrijk‐Antwerp Belgium

Ritse M. Mann

Department of Medical Imaging, Radboud University Medical Center, Nijmegen, the Netherlands

Heather Jacene

Dana-Farber Cancer Institute, Boston, MA

John P. Pilkington Woll

Department of PET-CT, Clinica Delgado AUNA, Lima, Perú

Isabel T. Rubio

Breast Surgical Unit, Clínica Universidad de Navarra, Madrid, Spain

Marie-Jeanne Vrancken Peeters

Department of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands

Stephanie L. Graff

Brown University Health Cancer Institute, The Warren Alpert Medical School of Brown University, Providence, RI

Fatima Cardoso